Chimeric Antigen Receptor (CAR) T-Cell Therapy: Engineering Immune Cells To Treat Liver Diseases

0
133
The authors present an overview of CAR technology’s fundamental principles and achievements, focusing on CAR-T cell applications in hepatic viral infections, autoimmune liver disease, and hepatobiliary tumors.
[Journal of Hepatology]
Full Article